Nintedanib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Nintedanib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Nintedanib included in the composition |
Prices in pharmacies |
| Vargatef | 1180-1470.8€ |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 61% Erlotinib
- 60% Encorafenib
- 50% Alectinib
- 49% Trametinib
- 49% Lorlatinib
- 49% Selpercatinib
- 46% Abemaciclib
- 41% Nivolumab
- 41% Sunitinib
- 41% Binimetinib
- 39% Hydrazine sulfate
- 39% Ramucirumab
- 38% Gallium [67Ga] citrate
- 38% Ceritinib
- 38% Capmatinib
- 38% Osimertinib
- 38% Afatinib
- 36% Cabozantinib
- 35% Regorafenib
- 34% Pemetrexed
- 34% Zanubrutinib
- 33% Axitinib
- 33% Palbociclib
- 33% Ibrutinib
- 32% Benzotef
- 32% Atezolizumab
- 32% Trastuzumab deruxtecan
- 30% Dasatinib
- 30% Pazopanib
- 29% Imatinib
- 29% Idarubicin
- 29% Vandetanib
- 29% Capivasertib
- 28% Cetuximab
- 28% Crizotinib
- 28% Camrelizumab
- 27% Ribociklib
- 27% Akalabrutinib
- 27% Sorafenib
- 27% Gefitinib
- 26% Docetaxel
- 26% Topotecan
- 25% Azacitidine
- 25% Pirfenidone
- 25% Panitumumab
- 25% Strontium chloride [89Sr]
- 25% Bosutinib
- 24% Vinorelbine
- 24% Nitrosomethylurea
- 23% Dipin
Learn more about the selection of analogues
▶
- The drug has «Nintedanib» 51 analog by action, the most similar - Erlotinib .
- Medical online service has selected the best substitutes for Nintedanib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Nintedanib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.